Synopsis: KPIT Technologies will announce its Q4FY26 and full-year results tomorrow, with expectations of better performance compared to the previous quarter. Revenue growth is likely to remain steady, while margins and profit will be important to watch as the company...
Synopsis: Blue Star is set to announce its Q4FY26 and full-year results tomorrow, with brokerages expecting improved performance supported by stronger summer demand and recovery in the room air conditioner segment. Revenue growth is likely to remain healthy, while...
Synopsis: Sona BLW is entering FY27 with record Q4 numbers, Rs. 1,269 crore cash and a large Rs. 237 billion order book. At a time when tariffs, EV volatility and supply chain resets are troubling global auto suppliers, management believes this disruption could help...
Synopsis: United Breweries is set to announce its Q4FY26 and full-year results tomorrow, with brokerages expecting modest revenue growth, improving margins, and mixed demand trends across markets. Premium portfolio growth, cost efficiencies, and regional performance...
Synopsis: Ather Energy’s Q4FY26 results could mark a major milestone as strong EV demand, dealership expansion, and new platform launches may help the company cross Rs. 1,000 crore in quarterly revenue for the first time. Ather Energy has informed the exchanges that a...
Synopsis: This Pharma-Chemical stock is a global Ibuprofen leader with a large integrated manufacturing base, low debt and new API expansion plans. But the bigger question is whether Paracetamol, non-Ibuprofen APIs, exports and regulated markets can turn this stable...
Synopsis: Symphony is entering the upcoming summer season after a weak FY26 demand cycle, but the company says trade inventory has largely normalized and its brand leadership remains strong. With new products, rural expansion, round-the-year categories and industrial...
Synopsis: Sona BLW is set to announce its Q4FY26 and full-year results today, with brokerages expecting strong revenue growth supported by EV momentum, order wins, and resilient margins. Investors will closely watch whether the auto ancillary major can sustain growth...
Synopsis: A pharma stock is trying to move from a small API and intermediates manufacturer into a larger integrated pharma platform. With capacity expansion, acquisitions, regulated market filings, CDMO plans and a new formulations push, the story looks exciting, but...
Synopsis: Waaree Energies and Vedanta are set to announce their Q4FY26 results on April 29, with brokerages expecting strong year-on-year growth but mixed sequential trends. While Waaree’s growth is driven by capacity expansion and solar demand, Vedanta’s performance...
